APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barry I. Freedman, MD
Wake Forest University Health Sciences
Principal Investigator - David M. Reboussin, PhD
Wake Forest University Health Sciences
Principal Investigator - Marva Moxey-Mims, MD
Children's Natl Health System; George Washington Univ Sch of Med and Health Serv
Study Chair - Paul L. Kimmel, MD
Natl Institute of Diabetes, Digestive & Kidney Diseases
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California San Francisco
San Francisco, California, United States
- University of Miami / Miami Transplant Institute
Miami, Florida, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Maryland School of Medicine
Baltimore, Maryland, United States
- Joslin Diabetes Center / Harvard University
Boston, Massachusetts, United States
- University of Michigan Medicine
Ann Arbor, Michigan, United States
- Saint Louis University Center for Transplantation
St Louis, Missouri, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Ichan School of Medicine at Mount Sinai
New York, New York, United States
- Weill Cornell Medicine
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Wisconsin - Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Mar 2019
- Primary completion
- 30 May 2027
- Completion
- 30 May 2027
- Last update posted
- 26 May 2026
- Registered enrollment
- 5,000
- Registry id
- NCT03615235
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.